{"altmetric_id":2717105,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["1391611821085186"],"posts_count":1},"news":{"unique_users_count":1,"unique_users":["bioportfolio"],"posts_count":1},"total":{"posts_count":7},"twitter":{"unique_users_count":5,"unique_users":["InOncology","TheLancetOncol","intervalolibre","edalex81","Terapiacomsrl"],"posts_count":5}},"selected_quotes":["Lancet Oncology: Mantenimiento del Pazopanib mejora supervivencia en c\u00e1ncer de ovario","Breaking news- Maintenance pazopanib increases progression-free survival versus with placebo in ovarian cancer #ovca"],"citation":{"altmetric_jid":"4f6fa4f73cf058f610002fd1","authors":["Ahmadur Rahman"],"doi":"10.1016\/s1470-2045(14)70264-5","first_seen_on":"2014-09-26T09:16:10+00:00","issns":["1470-2045","14702045"],"journal":"Lancet Oncology","last_mentioned_on":1412193604,"links":["http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045%2814%2970264-5\/fulltext","http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045%2814%2970264-5\/fulltext?rss=yes","http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(14)70264-5\/fulltext?rss=yes","http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(14)70264-5\/fulltext"],"pdf_url":"http:\/\/download.thelancet.com\/pdfs\/journals\/lanonc\/PIIS1470204514702645.pdf","pubdate":"2014-09-26T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Maintenance pazopanib in ovarian cancer ","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/maintenance-pazopanib-ovarian-cancer"},"altmetric_score":{"score":12.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.1},"context_for_score":{"all":{"total_number_of_other_articles":5040289,"mean":5.9643426109799,"rank":394480,"this_scored_higher_than_pct":92,"this_scored_higher_than":4644061,"rank_type":"exact","sample_size":5040289,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":136913,"mean":8.6324026381911,"rank":15183,"this_scored_higher_than_pct":88,"this_scored_higher_than":121659,"rank_type":"exact","sample_size":136913,"percentile":88},"this_journal":{"total_number_of_other_articles":2728,"mean":13.178831683168,"rank":569,"this_scored_higher_than_pct":78,"this_scored_higher_than":2155,"rank_type":"exact","sample_size":2728,"percentile":78},"similar_age_this_journal_3m":{"total_number_of_other_articles":131,"mean":13.307938461538,"rank":51,"this_scored_higher_than_pct":61,"this_scored_higher_than":80,"rank_type":"exact","sample_size":131,"percentile":61}}},"demographics":{"poster_types":{"member_of_the_public":5},"users":{"twitter":{"cohorts":{"Members of the public":4,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Student  > Postgraduate":1},"by_discipline":{"Medicine and Dentistry":2}}},"geo":{"twitter":{"IN":1,"GB":1,"VE":1},"mendeley":{"FR":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/InOncology\/status\/515652879068053504","license":"datasift","citation_ids":[2717105],"posted_on":"2014-09-27T00:03:21+00:00","author":{"name":"India Oncology 2.0","url":"https:\/\/www.facebook.com\/pages\/InOncology\/149384831739338","image":"https:\/\/pbs.twimg.com\/profile_images\/1075687841\/12_normal.png","description":"The Latest in Oncology","id_on_source":"InOncology","tweeter_id":"166079744","geo":{"lt":20,"ln":77,"country":"IN"},"followers":134},"tweet_id":"515652879068053504"},{"url":"https:\/\/twitter.com\/TheLancetOncol\/status\/515429316914847744","license":"datasift","citation_ids":[2717105],"posted_on":"2014-09-26T09:15:00+00:00","author":{"name":"The Lancet Oncology","url":"http:\/\/www.thelancet.com","image":"https:\/\/pbs.twimg.com\/profile_images\/441608748306423808\/qlozKasq_normal.jpeg","description":"The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer-reviewed research and reviews, comment, news, and Commissions.","id_on_source":"TheLancetOncol","tweeter_id":"50265238","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":11619},"tweet_id":"515429316914847744"},{"url":"https:\/\/twitter.com\/intervalolibre\/status\/515462555276677121","license":"datasift","citation_ids":[2717105],"posted_on":"2014-09-26T11:27:04+00:00","author":{"name":"Intervalolibre","url":"http:\/\/www.intervalolibre.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/898942384217739265\/Ub3BOuZE_normal.jpg","description":"Ginecolog\u00eda oncol\u00f3gica y mastolog\u00eda en tiempo libre. Gynecologic Oncology and Breast Cancer information in free time.","id_on_source":"intervalolibre","tweeter_id":"586173324","geo":{"lt":8,"ln":-66,"country":"VE"},"followers":1486},"tweet_id":"515462555276677121"},{"url":"https:\/\/twitter.com\/edalex81\/status\/515466422815047680","license":"datasift","rt":["intervalolibre"],"citation_ids":[2717105],"posted_on":"2014-09-26T11:42:26+00:00","author":{"name":"Edward A Cabrera A","image":"https:\/\/pbs.twimg.com\/profile_images\/548973035869700096\/F7a0jDkv_normal.jpeg","description":"Carupanero con calidad de exportacion, medico de corazon y profesion, y viviendo baja el hechizo del Avila","id_on_source":"edalex81","tweeter_id":"592604060","followers":648},"tweet_id":"515466422815047680"},{"url":"https:\/\/twitter.com\/Terapiacomsrl\/status\/517403595831267328","license":"datasift","citation_ids":[2717105],"posted_on":"2014-10-01T20:00:04+00:00","author":{"name":"Terapia Bartoccioni","url":"http:\/\/www.pocketmanualterapia.com","image":"https:\/\/pbs.twimg.com\/profile_images\/503820068778549248\/QTpjviMg_normal.jpeg","description":"Pocket Manual Terapia 2015 Bartoccioni","id_on_source":"Terapiacomsrl","tweeter_id":"2235023923","geo":{"lt":null,"ln":null},"followers":81},"tweet_id":"517403595831267328"}],"news":[{"title":"News Maintenance pazopanib in ovarian cancer","url":"http:\/\/www.bioportfolio.com\/news\/article\/2079124\/News-Maintenance-pazopanib-in-ovarian-cancer.html","license":"public","citation_ids":[2717105],"posted_on":"2014-09-27T01:19:01+00:00","summary":"Angiogenesis has been shown to play an important part in the growth of ovarian cancer and VEGF is a key driver of the process.","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}}],"facebook":[{"title":"Maintenance pazopanib in ovarian cancer : The Lancet Oncology","url":"https:\/\/www.facebook.com\/1391611821085186\/posts\/1504859213093779","license":"public","citation_ids":[2717105],"posted_on":"2014-10-01T20:00:01+00:00","summary":"Despite prematurely terminated accrual and the lack of information about post-progression treatment, both progression-free survival and overall survival were significantly improved with bevacizumab and capecitabine compared with bevacizumab alone as maint","author":{"name":"Terapia Bartoccioni","url":"https:\/\/www.facebook.com\/1391611821085186","facebook_wall_name":"Terapia Bartoccioni","image":"https:\/\/graph.facebook.com\/1391611821085186\/picture","id_on_source":"1391611821085186"}}]}}